share_log
Moomoo 24/7 ·  Apr 24 07:12
Innoviva Specialty Announced That Positive Results From The Phase 3 Oral Zoliflodacin Trial Will Be Highlighted In An Oral Presentation At The European Society Of Clinical Microbiology And Infectious Disease Global Congress
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment